Analysts Have Been Trimming Their Allbirds, Inc. (NASDAQ:BIRD) Price Target After Its Latest Report

In this article:

As you might know, Allbirds, Inc. (NASDAQ:BIRD) just kicked off its latest quarterly results with some very strong numbers. Revenues and losses per share were both better than expected, with revenues of US$52m leading estimates by 2.1%. Statutory losses were smaller than the analystsexpected, coming in at US$0.12 per share. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

See our latest analysis for Allbirds

earnings-and-revenue-growth
earnings-and-revenue-growth

Taking into account the latest results, the current consensus, from the five analysts covering Allbirds, is for revenues of US$195.6m in 2024. This implies an uneasy 11% reduction in Allbirds' revenue over the past 12 months. The loss per share is expected to greatly reduce in the near future, narrowing 27% to US$0.62. Yet prior to the latest earnings, the analysts had been forecasting revenues of US$197.0m and losses of US$0.65 per share in 2024. It looks like there's been a modest increase in sentiment in the recent updates, with the analysts becoming a bit more optimistic in their predictions for losses per share, even though the revenue numbers were unchanged.

The consensus price target fell 26% to US$0.85despite the forecast for smaller losses next year. It looks like the ongoing lack of profitability is starting to weigh on valuations. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. The most optimistic Allbirds analyst has a price target of US$1.00 per share, while the most pessimistic values it at US$0.70. This shows there is still a bit of diversity in estimates, but analysts don't appear to be totally split on the stock as though it might be a success or failure situation.

One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. One more thing stood out to us about these estimates, and it's the idea that Allbirds' decline is expected to accelerate, with revenues forecast to fall at an annualised rate of 21% to the end of 2024. This tops off a historical decline of 3.8% a year over the past three years. Compare this against analyst estimates for companies in the broader industry, which suggest that revenues (in aggregate) are expected to grow 5.8% annually. So while a broad number of companies are forecast to grow, unfortunately Allbirds is expected to see its revenue affected worse than other companies in the industry.

The Bottom Line

The most obvious conclusion is that the analysts made no changes to their forecasts for a loss next year. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that Allbirds' revenue is expected to perform worse than the wider industry. Furthermore, the analysts also cut their price targets, suggesting that the latest news has led to greater pessimism about the intrinsic value of the business.

Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. We have forecasts for Allbirds going out to 2026, and you can see them free on our platform here.

And what about risks? Every company has them, and we've spotted 5 warning signs for Allbirds you should know about.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Advertisement